Подборка Недвижимости в Сочи

FDA advisors prepare to vote on Moderna, J&J Covid boosters

3 (Просмотры)

Поделись этим постом у себя на странице!

A group of expert FDA advisors plan to meet over the coming days to discuss Moderna's and Johnson & Johnson's applications for a Covid-19 booster. CNBC's Meg Tirrell reports. For access to live and exclusive video from CNBC subscribe to CNBC PRO:

A key Food and Drug Administration panel is holding a meeting Thursday to discuss and vote on the use of booster shots of Moderna’s Covid-19 vaccine.

Depending on how the meeting goes, the agency could make a final decision within days, handing it off to the Centers for Disease Control and Prevention and its vaccine advisory committee to make their own decision.

FDA scientists declined to take a stance on whether to back booster shots of Moderna’s Covid vaccine in an unusual move Tuesday, saying the data shows currently authorized vaccines still protect against severe disease and death in the U.S.

Last month, U.S. regulators authorized Covid booster shots of Pfizer and BioNTech’s vaccine to a wide array of Americans, including the elderly, adults with underlying medical conditions, and those who work or live in high-risk settings like health and grocery workers.

» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30:

Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:

News USA today
Комментариев нет.